Kelyon company grows in foreign markets thanks to funding provided under an initiative promoted by SACE, EIF and CDP.
Cassa depositi e prestiti Group, through SACE, CDP and the European Investment Fund (EIF), is supporting digital health by extending a €300 thousand line of credit to Italy’s Kelyon.
The initiative is organized under “Programma 2i per l’impresa" ("2nd program for Enterprise"), which helps Italy’s small and medium-sized enterprises (SMEs) innovate and expand abroad through the resources of the European Fund for Strategic Investments (EFSI), commonly referred to as the Juncker Plan.
The operation is dedicated to Kelyon, a company founded in 2008 specializing in the design and development of medical devices software for prevention, diagnosis and treatment of patients with complex diseases. The funding will enable the company to embark on an international-growth path.
Among Kelyon’s 2017 objectives is the opening of a representative office in the UK to develop on the British market, and forge new partnerships with English universities – a stepping stone to forging new opportunities offered by the European and North American markets.
The funding, provided by Banca Monte dei Paschi di Siena and guaranteed by SACE under “Programma 2i per l’impresa”, will permit Kelyon to shoulder the costs associated with opening the new English structure, with the aim of creating an international Kelyon-like business. Kelyon currently counts on international business for one-third of its revenue, a considerable part arriving from some of the world’s biggest multinational pharmaceutical companies.
CDP Group, together with SACE and the EIB Group, renews its support for Italian SMEs and achieves goals set out in Business Plan 2016/2020.